Clinical Trials Browser

Phase NA × Recruiting × camrelizumab × Clear all

NCT05772273 2025-11-21

PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06061276 2024-09-23

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT05202314 2023-02-21

NACSOC-02

Phase NA Recruiting

Gastrointestinal

Bites and Stings, Colorectal Neoplasms